These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33290599)

  • 1. Innovative features and functionalities of an artificial pancreas system: What do youth and parents want?
    Commissariat PV; Volkening LK; Butler DA; Dassau E; Weinzimer SA; Laffel LM
    Diabet Med; 2021 Oct; 38(10):e14492. PubMed ID: 33290599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Youth and parent preferences for an ideal AP system: It is all about reducing burden.
    Commissariat PV; Roethke LC; Finnegan JL; Guo Z; Volkening LK; Butler DA; Dassau E; Weinzimer SA; Laffel LM
    Pediatr Diabetes; 2021 Nov; 22(7):1063-1070. PubMed ID: 34324772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future artificial pancreas technology for type 1 diabetes: what do users want?
    Barnard KD; Pinsker JE; Oliver N; Astle A; Dassau E; Kerr D
    Diabetes Technol Ther; 2015 May; 17(5):311-5. PubMed ID: 25629627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future acceptance of an artificial pancreas in adults with type 1 diabetes.
    van Bon AC; Brouwer TB; von Basum G; Hoekstra JB; DeVries JH
    Diabetes Technol Ther; 2011 Jul; 13(7):731-6. PubMed ID: 21504332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I'm essentially his pancreas": Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes.
    Commissariat PV; Harrington KR; Whitehouse AL; Miller KM; Hilliard ME; Van Name M; DeSalvo DJ; Tamborlane WV; Anderson BJ; DiMeglio LA; Laffel LM
    Pediatr Diabetes; 2020 Mar; 21(2):377-383. PubMed ID: 31808586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting.
    Troncone A; Bonfanti R; Iafusco D; Rabbone I; Sabbion A; Schiaffini R; Galderisi A; Marigliano M; Rapini N; Rigamonti A; Tinti D; Vallone V; Zanfardino A; Boscari F; Del Favero S; Galasso S; Lanzola G; Messori M; Di Palma F; Visentin R; Calore R; Leal Y; Magni L; Losiouk E; Chernavvsky D; Quaglini S; Cobelli C; Bruttomesso D
    Diabetes Care; 2016 Dec; 39(12):2158-2164. PubMed ID: 27852685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes.
    Elleri D; Acerini CL; Allen JM; Hayes J; Pesterfield C; Wilinska ME; Dunger DB; Hovorka R
    Diabetes Technol Ther; 2010 Jan; 12(1):35-9. PubMed ID: 20082583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online survey.
    Taleb N; Quintal A; Rakheja R; Messier V; Legault L; Racine E; Rabasa-Lhoret R
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):658-665. PubMed ID: 33358714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
    Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
    Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial Aspects of Diabetes Technology Use: The Child and Family Perspective.
    Papadakis JL; Anderson LM; Garza K; Feldman MA; Shapiro JB; Evans M; Thompson LG; Weissberg-Benchell J
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):127-141. PubMed ID: 31980113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes.
    Commissariat PV; Whitehouse AL; Hilliard ME; Miller KM; Harrington KR; Levy W; DeSalvo DJ; Van Name MA; Anderson BJ; Tamborlane WV; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2020 Sep; 22(9):697-700. PubMed ID: 32077755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
    Gildersleeve R; Riggs SL; Cherñavvsky DR; Breton MD; DeBoer MD
    Diabetes Technol Ther; 2017 Nov; 19(11):660-674. PubMed ID: 28854339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.
    Kropff J; DeJong J; Del Favero S; Place J; Messori M; Coestier B; Farret A; Boscari F; Galasso S; Avogaro A; Bruttomesso D; Cobelli C; Renard E; Magni L; DeVries JH;
    Diabet Med; 2017 Feb; 34(2):262-271. PubMed ID: 27696520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes.
    Young AJ; Thabit H; Heller SR; Evans ML; Amiel SA; Hovorka R; Barnard KD
    J Diabetes Sci Technol; 2015 Jul; 9(4):932-3. PubMed ID: 25852073
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What End Users and Stakeholders Want From Automated Insulin Delivery Systems.
    Naranjo D; Suttiratana SC; Iturralde E; Barnard KD; Weissberg-Benchell J; Laffel L; Hood KK
    Diabetes Care; 2017 Nov; 40(11):1453-1461. PubMed ID: 28842523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.